Area of research
Reproductive Medicine · Oncology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, COVID-19 and healthcare impacts, Cancer Immunotherapy and Biomarkers, and COVID-19 Clinical Research Studies.
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
Abstract B047: Development and validation of an improved risk stratification model for ovarian cancer
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
A framework for assessing interactions for risk stratification models: the example of ovarian cancer
Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia
Profiling the immune landscape in mucinous ovarian carcinoma
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Effects of risk factors for ovarian cancer in women with and without endometriosis
Reproductive Factors Do Not Influence Survival with Ovarian Cancer
2022cited by 2position: last
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association
Association Between Breastfeeding and Ovarian Cancer Risk
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case–control studies
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study
Assessment of Polygenic Architecture and Risk Prediction based on Common Variants Across Fourteen Cancers
Identification of novel epithelial ovarian cancer loci in women of African ancestry
Population based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high grade serous ovarian cancer
A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome‐wide significant common variants
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies